Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | GNRHR | P30968 | 8/20 | 0.44 |
| ▸ | MEN1 | O00255 | 4/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.42 |
| ▸ | GSK3B | P49841 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | PPP1CA | P62136 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7202144 | 0.87 | GNRHR (0.46) | ALDH1A1HTTGNRHRMEN1KMT2A | |
| SCHEMBL7747096 | 0.83 | ALDH1A1 (0.46) | ALDH1A1GNRHRMEN1KMT2ALMNA | |
| SCHEMBL29696460 | 0.80 | SLC11A2 (0.37) | ALDH1A1HTTGNRHRMEN1KMT2A | |
| SCHEMBL29696469 | 0.80 | SLC11A2 (0.37) | ALDH1A1GNRHRMEN1KMT2ALMNA | |
| SCHEMBL29382466 | 0.79 | APP (0.34) | GNRHRMEN1KMT2ALMNAPOLB | |
| SCHEMBL29696435 | 0.78 | SLC11A2 (0.37) | ALDH1A1HTTGNRHRMEN1KMT2A | |
| SCHEMBL29696443 | 0.78 | SLC11A2 (0.37) | ALDH1A1HTTGNRHRMEN1KMT2A | |
| SCHEMBL29696456 | 0.77 | SLC11A2 (0.38) | ALDH1A1HTTGNRHRMEN1KMT2A | |
| SCHEMBL29696450 | 0.77 | SLC11A2 (0.35) | ALDH1A1HTTGNRHRMEN1KMT2A | |
| SCHEMBL29634921 | 0.75 | SIRT2 (0.39) | ALDH1A1HTTMEN1KMT2ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1917978-B1 | Premature ovulation preventive agent | TAKEDA PHARMACEUTICAL (JP) | 2014-08-20 | — | — | EP | disclosed |
| US-20090048273-A1 | PREMATURE OVULATION PREVENTIVE AGENT | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-02-19 | — | — | US | disclosed |
| EP-1917978-A1 | PREMATURE OVULATION PREVENTIVE AGENT | Takeda Pharmaceutical Company Limited (JP) | 2008-05-07 | — | — | EP | disclosed |
| US-20040116522-A1 | Medicinal solutions | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2004-06-17 | — | — | US | disclosed |
| EP-1163244-B1 | THIENOPYRIMIDINE COMPOUNDS, THEIR PRODUCTION AND USE | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 2004-03-10 | — | — | EP | disclosed |
| EP-1393747-A1 | PREVENTIVES/REMEDIES FOR ALZHEIMER'S DISEASE | Takeda Chemical Industries, Ltd. (JP) | 2004-03-03 | — | — | EP | disclosed |
| US-20040034039-A1 | Solid preparations | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2004-02-19 | — | — | US | disclosed |
| US-20040023987-A1 | Sustained release compositions | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2004-02-05 | — | — | US | disclosed |
| EP-1374855-A1 | MEDICINAL SOLUTIONS | Takeda Chemical Industries, Ltd. (JP) | 2004-01-02 | — | — | EP | disclosed |
| EP-0808317-B1 | THIENOPYRIMIDINE DERIVATIVES, THEIR PRODUCTION AND USE | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 2003-09-10 | — | — | EP | disclosed |
| US-20030134863-A1 | Preventives/remedies for alzheimer's disease | TAKEDA CHEMICAL INDUSTRIES LTD. (JP) | 2003-07-17 | — | — | US | disclosed |
| EP-1319409-A1 | SOLID PREPARATIONS | Takeda Chemical Industries, Ltd. (JP) | 2003-06-18 | — | — | EP | disclosed |
| EP-1291023-A1 | SUSTAINED RELEASE COMPOSITIONS | Takeda Chemical Industries, Ltd. (JP) | 2003-03-12 | — | — | EP | disclosed |
| US-6340686-B1 | GONADOTROPIN-RELEASING HORMONE ANTAGONISTS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2002-01-22 | — | — | US | disclosed |
| US-6297379-B1 | GONADOTROPIN RELEASING HORMONE (GNRH, SOMETIMES CALLED LH-RH (LUTEINIZING HORMONE RELEASING HORMONE)) ANTAGONIZING ACTIVITY, TREATING SEX HORMONE-DEPENDENT DISEASES. | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2001-10-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030134863-A1 | Preventives/remedies for alzheimer's disease | ACHE, GNRHR, PSEN1 | ALDH1A1 2627/4885HTT 15/4885GNRHR 2/4885 |
| US-20040023987-A1 | Sustained release compositions | NGLY1, GHSR, GHRHR | ALDH1A1 4808/4885HTT 1836/4885GNRHR 46/4885 |
| US-20040034039-A1 | Solid preparations | GYS1, GYS2, SI | ALDH1A1 2943/4885HTT 3970/4885GNRHR 3501/4885 |
| US-20090048273-A1 | PREMATURE OVULATION PREVENTIVE AGENT | GNRHR, FSHR, LHCGR | ALDH1A1 4291/4885HTT 1229/4885GNRHR 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.